Clinical Trial Update: ONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant [Phase 1]

View source ↗

Summary

Phase 1 trial of ONC-201 as maintenance therapy after stem cell transplant in acute myeloid leukemia and myelodysplastic syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• ONC-201 (ONC-201)

Snippet

Sponsor: University of Nebraska | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED